PRINCETON, NJ--(Marketwire - Nov 14, 2012) - Agile Therapeutics commercial head Katie MacFarlane has been named a Bronze Stevie Winner for the Female Entrepreneur of the Year Stevie® Award in the Consumer Products, 10 or Fewer Employees category, in the Stevie Awards for Women in Business.
The Stevie Awards for Women in Business are the world's top honors for female entrepreneurs, executives, and the organizations they run. All individuals and organizations worldwide are eligible to submit nominations -- public and private, for-profit and non-profit, large and small. The 2012 awards received entries from 17 nations and territories.
Nicknamed the Stevies for the Greek word for "crowned," the awards were presented to winners during a dinner at the Marriott Marquis Hotel in New York City.
Dr. MacFarlane is the commercial head of Agile Therapeutics, and brings over 23 years of experience in the pharmaceutical industry, including drug development, marketing, and sales management. She is leading the preapproval commercial activities for AG200-15, the company's once-weekly, low-dose contraceptive patch, which was recently submitted to the FDA for approval.
"We are so proud of Katie for being named a winner of this prestigious award," said Al Altomari, President and CEO of Agile Therapeutics. "She has played an instrumental role in supporting our development and preparation for marketing of AG200-15, and this recognition is a testament to her hard work at Agile and her extensive experience in the pharmaceutical industry."
Stevie Award winners were selected by more than 200 executives worldwide who participated in the judging process this year.
"I'm very pleased that we were able to conclude our tenth year of organizing Stevie Awards programs with a very successful Women in Business event," said Michael Gallagher, president and founder of the Stevie Awards. "This year's Stevie Award-winning women are the most accomplished, impressive group we've ever had. Their stories of success will be an inspiration to women around the globe who dream of starting and growing a business and making a difference in the world."
Details about the Stevie Awards for Women in Business and the list of Stevie Award winners are available at www.StevieAwards.com/Women.
About Agile Therapeutics
Agile Therapeutics is a pharmaceutical development company specializing in Women's Healthcare products, with an initial focus on providing women with more options and potentially more convenient methods of hormonal contraception. The company's lead investigational product, AG200-15, is designed to be a once-weekly contraceptive patch that has recently been submitted to the FDA as a New Drug Application (NDA) for review. In addition, Agile is also developing a low dose, progestin-only contraceptive patch, AG890 (formerly AG900). Both AG200-15 and AG890 incorporate proprietary transdermal delivery technology, Skinfusion®, developed by Agile, consisting of an active and peripheral adhesive system that has been designed to allow stable drug delivery and dependable adhesion over seven days. For more information, please visit http://www.agiletherapeutics.com.
About the Stevie Awards
Stevie Awards are conferred in four programs: The International Business Awards, The American Business Awards, the Stevie Awards for Women in Business, and the Stevie Awards for Sales & Customer Service. Honoring organizations of all types and sizes and the people behind them, the Stevies recognize outstanding performances in the workplace worldwide. Learn more about The Stevie Awards at www.StevieAwards.com.